Real-world use of the FIB-4 calculator in primary care workflows to screen for advanced non-alcoholic fatty liver disease in a large US health system

被引：0

作者：

Therapondos, George ^{[1
]}

Thomas, Anna ^{[2
]}

Dieterich, Douglas T. ^{[3
]}

Girgrah, Nigel ^{[1
]}

Oravetz, Philip ^{[4
]}

机构：

[1] Ochsner Hlth, Multiorgan Transplant, New Orleans, LA USA

[2] NASHNET, Kiev, Ukraine

[3] Icahn Sch Med, Dept Med, New York, NY USA

[4] Ochsner Hlth, Populat Hlth, New Orleans, LA USA

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI070

引用

页码：S432 / S432

页数：1

共 50 条

[41] Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians
Younossi, Zobair
Yilmaz, Yusuf
El Kassas, Mohammed
Wong, Vincent Wai-Sun
Duseja, Ajay Kumar
Mendez-Sanchez, Nahum
George, Jacob
Chan, Wah-Kheong
Castera, Laurent
Arrese, Marco
Alswat, Khaled
Takahashi, Hirokazu
Gomez, Manuel Romero
Ong, Janus
Ziayee, Mariam
Younossi, Issah
Racila, Andrei
Stepanova, Maria
JOURNAL OF HEPATOLOGY, 2020, 73 : S440 - S440
[42] Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease
Kraus, Emily M.
Pierce, Samantha Lange
Porter, Renee
Kompaniyets, Lyudmyla
Vos, Miriam B.
Blanck, Heidi M.
King, Raymond J.
Goodman, Alyson B.
CHILDHOOD OBESITY, 2024, 20 (01) : 41 - 47
[43] A COMPARISON OF MR ELASTOGRAPHY (MRE) TO BIOMARKER TESTING USING FIB-4 AND NAFLD FIBROSIS SCORES FOR STAGING LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Kaplan, Joseph
Alexis, Jamil
Grimaldi, Gregory
Lee, Tai-Ping
GASTROENTEROLOGY, 2020, 158 (06) : S1409 - S1409
[44] ETHNIC DIFFERENCES IN LIVER AND MORTALITY OUTCOMES OF NON-ALCOHOLIC FATTY LIVER DISEASE: A REAL-WORLD STUDY WITH LONGITUDINAL FOLLOW-UP
Nguyen, Vy H.
Le, Isaac
Ha, Audrey
Le, Richard H.
Rouillard, Nicholas
Fong, Ashley
Gudapati, Surya T.
Park, Jung Eun
Maeda, Mayumi
Barnett, Scott
Henry, Linda
Cheung, Ramsey
Nguyen, Mindie H.
GASTROENTEROLOGY, 2023, 164 (06) : S1289 - S1290
[45] Reply to correspondence on "Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study"
Bae, Jae Hyun
CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
[46] Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study
Sun, Wenjing
Cui, Hongli
Li, Ning
Wei, Yanling
Lai, Shujie
Yang, Yang
Yin, Xinru
Chen, Dong-Feng
HEPATOLOGY RESEARCH, 2016, 46 (09) : 862 - 870
[47] Effectiveness of RESET care program: A real-world-evidence on managing non-alcoholic fatty liver disease through digital health interventions
Soni, Jayesh
Pathak, Nikhilesh
Gharia, Mihir
Aswal, Devina
Parikh, Jaymin
Sharma, Prachi
Mishra, Astha
Lalan, Dhvni
Maheshwari, Twinkle
WORLD JOURNAL OF HEPATOLOGY, 2025, 17 (01)
[48] Performance of non-invasive biomarkers and transient elastography for predicting liver fibrosis in patients with non-alcoholic fatty liver disease: A real-world evaluation
Zhu, J.
Majeed, A.
Roberts, S.
Kemp, W.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 88 - 88
[49] CAN ADVANCED FIBROSIS RELIABLY EXCLUDED BY SIMPLE NON-INVASIVE FIBROSIS SCORING SYSTEMS?: PERFORMANCE OF FIB-4 AND NFS IN A BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE SAMPLE
Kaya, Eda
Bakir, Alev
Yilmaz, Yusuf
HEPATOLOGY, 2019, 70 : 1053A - 1054A
[50] FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
Amernia, Behnaz
Moosavy, Seyed Hamid
Banookh, Fatemeh
Zoghi, Ghazal
BMC GASTROENTEROLOGY, 2021, 21 (01)

← 1 2 3 4 5 →